ENDRA Life Sciences Inc.

Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
Returns
Key stats
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Financials
About ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.
Frequently asked questions
To buy ENDRA Life Sciences Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for ENDRA Life Sciences Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for ENDRA Life Sciences Inc. is NDRA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
ENDRA Life Sciences Inc. has its primary listing on NASDAQ (Small cap). You can trade ENDRA Life Sciences Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, ENDRA Life Sciences Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include ENDRA Life Sciences Inc. as part of a broader investment portfolio.